Trial intelligence / Profile preview

Effects of BAK on Blood-Aqueous Barrier in Pseudophakic Patients

NCT01280110Phase 4Completed

Sponsor
Universidade Estadual de Campinas
Start
Mar 2011
Primary completion
Dec 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of benzalkonium chloride in dry eye syndrome (DED), sponsored by Universidade Estadual de Campinas. Started Mar 2011; status: completed.

02

Drugs

benzalkonium chloride
03

Conditions

dry eye syndrome (DED)

Beyond the preview

Go deeper on NCT01280110.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01280110.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call